A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial
摘要:
From the structure of 3,3-dimethyl-3H-benzofuro[3,2-f][1]-benzopyran, a selective in vitro inhibitor of mycobacterial growth, we have undertaken a structure-activity relationship investigation. We wish to report here our results on the use of [2+3] cycloadditions between 2-formylbenzoquinone and various enol derivatives to give various 4-formyl-5-hydroxy benzofurans. In the next step, an ytterbium triflate-catalysed reaction with 2-methylpropene allowed the preparation of various original furo[3,2-f]chromenes derivatives. Their biological evaluation on the growth of Mycobacterium smegmatis as well as Mycobacterium tuberculosis pointed out that some analogues were four times more active than the initial hit. (C) 2008 Elsevier Ltd. All rights reserved.
A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial
摘要:
From the structure of 3,3-dimethyl-3H-benzofuro[3,2-f][1]-benzopyran, a selective in vitro inhibitor of mycobacterial growth, we have undertaken a structure-activity relationship investigation. We wish to report here our results on the use of [2+3] cycloadditions between 2-formylbenzoquinone and various enol derivatives to give various 4-formyl-5-hydroxy benzofurans. In the next step, an ytterbium triflate-catalysed reaction with 2-methylpropene allowed the preparation of various original furo[3,2-f]chromenes derivatives. Their biological evaluation on the growth of Mycobacterium smegmatis as well as Mycobacterium tuberculosis pointed out that some analogues were four times more active than the initial hit. (C) 2008 Elsevier Ltd. All rights reserved.
[EN] PYRANODIBENZOFURAN DERIVATIVES WITH ANTIFUNGAL AND ANTIBACTERIAL ACTIVITY<br/>[FR] DÉRIVÉS DE PYRANODIBENZOFURANE PRÉSENTANT UNE ACTIVITÉ ANTIFONGIQUE ET ANTIBACTÉRIENNE
申请人:PASTEUR INSTITUT
公开号:WO2007039609A1
公开(公告)日:2007-04-12
[EN] Compound of the general formula (I): and in particular compounds of formula (II), (III), (IV), their process of preparation and their use as medicament for the treatment of fungal or bacterial infections, in particular mycobacterial infection. [FR] La présente invention a pour objet un composé de formule générale (I) : et en particulier les composés de formule (II), (III), (IV), leur procédé de synthèse et leur emploi en tant que médicament dans le traitement d'infections fongiques ou bactériennes, en particulier d'une infection mycobactérienne.